C M Gibson
Overview
Explore the profile of C M Gibson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
3127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gibson C, Hankey G, Nafee T, Welsh R
Thromb Haemost
. 2018 Mar;
118(S 01):S34-S44.
PMID: 29566416
With improved life expectancy and the aging population, the global burden of atrial fibrillation (AF) continues to increase, and with AF comes an estimated fivefold increased risk of ischaemic stroke....
2.
Chi G, Goldhaber S, Kittelson J, Turpie A, Hernandez A, Hull R, et al.
J Thromb Haemost
. 2017 Aug;
15(10):1913-1922.
PMID: 28762617
Summary: Background Among acutely ill hospitalized medical patients, extended-duration thromboprophylaxis reduces the risk of venous thromboembolism (VTE), but some pharmacologic strategies have been associated with greater risks of major bleeding,...
3.
Cohen A, Harrington R, Goldhaber S, Hull R, Gibson C, Hernandez A, et al.
Am Heart J
. 2014 Dec;
169(1):186-7.
PMID: 25497265
No abstract available.
4.
Oziminski W, Palusiak M, Dominikowska J, Krygowski T, Havenith R, Gibson C, et al.
Phys Chem Chem Phys
. 2013 Jan;
15(9):3286-93.
PMID: 23358331
The ring-current aromaticity of the bicalicene molecule arises, in spite of the 16 π carbon perimeter, from strong local diatropic circulations on the two pentagonal rings, as shown by current-density...
5.
Kunadian V, Gibson C
Drugs Today (Barc)
. 2011 Oct;
47(7):559-70.
PMID: 22013562
Although acute ST elevation myocardial infarction (STEMI) was described nearly a century ago, it remains a major health problem not only in the U.S. but also worldwide with more than...
6.
Navarese E, De Luca G, Castriota F, Kozinski M, Gurbel P, Gibson C, et al.
J Thromb Haemost
. 2011 Jul;
9(10):1902-15.
PMID: 21777368
Background: The aim of the current study was to perform two separate meta-analyses of available studies comparing low-molecular-weight heparins (LMWHs) vs. unfractionated heparin (UFH) in ST-elevation myocardial infarction (STEMI) patients...
7.
Gibson C, Safian R
Trends Cardiovasc Med
. 2011 Jan;
2(4):156-60.
PMID: 21239263
In coronary cineangiography, all components of the imaging chain are potential sources of image distortion. An understanding of these limitations is important to the understanding of the utility and limitations...
8.
Angiolillo D, Gibson C, Cheng S, Ollier C, Nicolas O, Bergougnan L, et al.
Clin Pharmacol Ther
. 2010 Sep;
89(1):65-74.
PMID: 20844485
Four randomized, placebo-controlled, crossover studies were conducted among 282 healthy subjects to investigate whether an interaction exists between clopidogrel (300-mg loading dose/75-mg/day maintenance dose) and the proton-pump inhibitor (PPI) omeprazole...
9.
Mega J, Braunwald E, Mohanavelu S, Burton P, Poulter R, Misselwitz F, et al.
Lancet
. 2009 Jun;
374(9683):29-38.
PMID: 19539361
Background: Rivaroxaban is an oral direct factor Xa inhibitor that has been effective in prevention of venous thromboembolism in patients undergoing elective orthopaedic surgery. However, its use after acute coronary...
10.
De Luca G, Gibson C, Bellandi F, Murphy S, Maioli M, Noc M, et al.
Heart
. 2008 May;
94(12):1548-58.
PMID: 18474534
Background: Even though time-to-treatment has been shown to be a determinant of mortality in primary angioplasty, the potential benefits from early pharmacological reperfusion by glycoprotein (Gp) IIb-IIIa inhibitors are still...